UNODC Strategic Plan: 2021 - 2025

UNODC’s mission is to contribute to global peace and security, human rights and development by making the world safer from drugs, crime, corruption and terrorism.

Watch a message from Ghada Waly

Outcome Document of the 2016 United Nations General Assembly Special Session on the World Drug Problem

We, Heads of State and Government, ministers and representatives of Member States, are assembled at United Nations Headquarters from 19 to 21 April 2016 for the thirtieth special session of the General Assembly, convened in accordance with Assembly resolution...

Final Act of the United Nations Conference for the Adoption of a Single Convention on Narcotic Drugs

The Economic and Social Council of the United Nations, by resolution 689 J (XXVI) of 28 July 1958, decided to convene in accordance with Article 62, paragraph 4, of the Charter of the United Nations,...

2020 World Drug Report

This is a time for science and solidarity, as United Nations Secretary-General António Guterres has said, highlighting the importance of trust in science and of working together to respond to the global COVID19 pandemic...

Progress in Ensuring Adequate Access to Internationally Controlled Substances for Medical and Scientific Purposes

The recommendations on the availability of internationally controlled drugs for medical and scientific purposes formulated by the International Narcotics Control Board (INCB) in the supplement to its annual report for 2015¹ and those contained in the outcome...

Availability of Internationally Controlled Drugs: Ensuring Adequate Access for Medical and Scientific Purposes

Indispensable and adequately available for medical and scientific purposes: those two fundamental principles were set forth in the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol. Later, psychotropic substances...

Training Material: 1961 Single Convention on Narcotic Drugs

The Single Convention on Narcotic Drugs, 1961 was adopted by Governments at a special international conference on 30 March 1961 in New York and entered in force in 1964. It replaces previous treaties on the control of opiates...

Scoping Document: WHO Guideline on Ensuring Balanced National Policies for Access and Safe Use of Controlled Medicines

Access to medicines is a key component of the attainment of universal health coverage, which is central to the health-related Sustainable Development Goal.¹ Controlled medicines include narcotics, such as opioids, and psychotropic substances...

Strengthening of Palliative Care as a Component of Comprehensive Care Throughout the Life Course

The Sixty-seventh World Health Assembly,

Having considered the report on strengthening of palliative care as a component of integrated treatment throughout the life course;¹...

Strengthening of Palliative Care as a Component of Integrated Treatment within the Continuum of Care

The Executive Board,

Having considered the report on strengthening of palliative care as a component of integrated treatment throughout the life course,¹...

Global Atlas of Palliative Care at the End of Life

Palliative care, while still a relatively new component to modern healthcare, is increasingly recognised as an essential part of all healthcare systems. Despite this, it is widely acknowledged that there is still inadequate access...

Consensus Statement for Palliative Care Integration into Health Systems in Africa: “Palliative Care for Africa”

On the occasion of the first African Ministers of Health session on palliative care at the APCA/HPCA African Palliative Care conference, 17th September 2013, Birchwood Conference Centre, Johannesburg, South Africa...

5th Session of the AU Conference of Ministers of Drug Control: African Common Position on Controlled Substances and Access to Pain Management Drugs

The overall goal of a functioning system for managing the availability of narcotic drugs and psychotropic substances should be to provide relief from pain and suffering by ensuring the safe delivery of the best affordable drugs...